141 related articles for article (PubMed ID: 32205472)
21. Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
Lahu S; Adler K; Mayer K; Hein-Rothweiler R; Bernlochner I; Ndrepepa G; Schüpke S; Holdenrieder S; Bongiovanni D; Laugwitz KL; Schunkert H; Gawaz M; Massberg S; Kastrati A; Münch G
Thromb Haemost; 2024 Apr; 124(4):297-306. PubMed ID: 37591289
[TBL] [Abstract][Full Text] [Related]
22. Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke.
Wurster T; Poetz O; Stellos K; Kremmer E; Melms A; Schuster A; Nagel E; Joos T; Gawaz M; Bigalke B
Platelets; 2013; 24(7):560-5. PubMed ID: 23215725
[TBL] [Abstract][Full Text] [Related]
23. Nox2-mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin.
Cammisotto V; Carnevale R; Nocella C; Stefanini L; Bartimoccia S; Coluccia A; Silvestri R; Pignatelli P; Pastori D; Violi F
Biochem Pharmacol; 2019 May; 163():111-118. PubMed ID: 30771281
[TBL] [Abstract][Full Text] [Related]
24. Measuring soluble platelet glycoprotein VI in human plasma by ELISA.
Al-Tamimi M; Mu FT; Moroi M; Gardiner EE; Berndt MC; Andrews RK
Platelets; 2009 May; 20(3):143-9. PubMed ID: 19437330
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of receptor shedding-platelet GPVI as an emerging diagnostic and therapeutic tool.
Chatterjee M; Gawaz M
Platelets; 2017 Jun; 28(4):362-371. PubMed ID: 27753514
[TBL] [Abstract][Full Text] [Related]
26. Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus Erythematosus.
Nhek S; Clancy R; Lee KA; Allen NM; Barrett TJ; Marcantoni E; Nwaukoni J; Rasmussen S; Rubin M; Newman JD; Buyon JP; Berger JS
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):707-716. PubMed ID: 28153882
[TBL] [Abstract][Full Text] [Related]
27. Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activation.
Egan K; Dillon A; Dunne E; Kevane B; Galvin Z; Maguire P; Kenny D; Stewart S; Ainle FN
J Thromb Thrombolysis; 2017 Jan; 43(1):54-59. PubMed ID: 27416950
[TBL] [Abstract][Full Text] [Related]
28. Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban.
Aota T; Naitoh K; Wada H; Yamashita Y; Miyamoto N; Hasegawa M; Wakabayashi H; Yoshida K; Asanuma K; Matsumoto T; Ohishi K; Shimokariya Y; Yamada N; Nishikawa M; Katayama N; Uchida A; Sudo A
Int J Hematol; 2014 Nov; 100(5):450-6. PubMed ID: 25253166
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of circulating immune complexes and antiphospholipid antibodies (anti beta 2 glycoprotein 1) in heroin addicts and their clinical significance.
Simonovska N; Chibishev A; Bozinovska C; Grcevska L; Dimitrovski K; Neceva V
Med Arh; 2011; 65(6):324-6. PubMed ID: 22299289
[TBL] [Abstract][Full Text] [Related]
30. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
31. Implications of glycoprotein VI for theranostics.
Gawaz M; Vogel S; Pfannenberg C; Pichler B; Langer H; Bigalke B
Thromb Haemost; 2014 Jul; 112(1):26-31. PubMed ID: 24553806
[TBL] [Abstract][Full Text] [Related]
32. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease.
Laske C; Leyhe T; Stransky E; Eschweiler GW; Bueltmann A; Langer H; Stellos K; Gawaz M
J Psychiatr Res; 2008 Jul; 42(9):746-51. PubMed ID: 17854831
[TBL] [Abstract][Full Text] [Related]
33. A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway.
Dunkley S; Arthur JF; Evans S; Gardiner EE; Shen Y; Andrews RK
Br J Haematol; 2007 Jun; 137(6):569-77. PubMed ID: 17539777
[TBL] [Abstract][Full Text] [Related]
34. Soluble glycoprotein VI is a predictor of major bleeding in patients with suspected heparin-induced thrombocytopenia.
Pishko AM; Andrews RK; Gardiner EE; Lefler DS; Cuker A
Blood Adv; 2020 Sep; 4(18):4327-4332. PubMed ID: 32915974
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
36. Diesel exhaust particles impair platelet response to collagen and are associated with GPIbα shedding.
Forestier M; Al-Tamimi M; Gardiner EE; Hermann C; Meyer SC; Beer JH
Toxicol In Vitro; 2012 Sep; 26(6):930-8. PubMed ID: 22542759
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI.
Nurden AT
Blood Rev; 2019 Nov; 38():100592. PubMed ID: 31351674
[TBL] [Abstract][Full Text] [Related]
38. Shear-induced platelet receptor shedding by non-physiological high shear stress with short exposure time: glycoprotein Ibα and glycoprotein VI.
Chen Z; Mondal NK; Ding J; Gao J; Griffith BP; Wu ZJ
Thromb Res; 2015 Apr; 135(4):692-8. PubMed ID: 25677981
[TBL] [Abstract][Full Text] [Related]
39. FcγRIIB on liver sinusoidal endothelial cells is essential for antibody-induced GPVI ectodomain shedding in mice.
Stegner D; Popp M; Lorenz V; Wax JK; Gessner JE; Nieswandt B
Blood; 2016 Aug; 128(6):862-5. PubMed ID: 27297794
[TBL] [Abstract][Full Text] [Related]
40. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
